Intracellular accumulation and immunological properties of fluorescent gold nanoclusters in human dendritic cells

Biomaterials

Volumn 43, Issue 1, 2015, Pages 1-12

  Fernández, Tahia D ^a   Pearson, John R ^b   Leal, Manuel Pernia ^b   Torres, Maria J ^a,c   Blanca, Miguel ^a,c   Mayorga, Cristobalina ^a,c   Le Guével, Xavier ^b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Cellular uptake; Fluorescence; Gold nanoclusters; Immune response; Monocyte derived dendritic cells

Indexed keywords

BODY FLUIDS; CYTOLOGY; CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE; GOLD; IMMUNE SYSTEM; LIGANDS; NANOCLUSTERS; PARTICLE SIZE;

CELLULAR UPTAKE; CONCENTRATION-DEPENDENT; DENDRITIC CELLS; GOLD NANOCLUSTER; IMMUNE RESPONSE; IMMUNOLOGICAL PROPERTIES; INTRACELLULAR ACCUMULATION; PHOTOLUMINESCENCE PROPERTIES;

CELLS;

AMPHOLYTE; FLUORESCENT GOLD NANOCLUSTER; GOLD NANOPARTICLE; IMMUNOSUPPRESSIVE AGENT; LIGAND; UNCLASSIFIED DRUG; AMINE; CD56 ANTIGEN; FLUORESCENT DYE; GOLD; METAL NANOPARTICLE;

ADAPTIVE IMMUNITY; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL ORGANELLE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; ENDOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERNALIZATION; MOLECULAR WEIGHT; MONOCYTE; PARTICLE SIZE; PERIPHERAL LYMPHOCYTE; PHOTOLUMINESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURFACE CHARGE; TH1 CELL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENDOCYTOSIS; IMMUNE SYSTEM; LYMPHOCYTE; METABOLISM; NANOMEDICINE;

AMINES; ANTIGENS, CD56; CELL PROLIFERATION; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENT DYES; GOLD; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; LYMPHOCYTES; METAL NANOPARTICLES; MICROSCOPY, CONFOCAL; NANOMEDICINE; PARTICLE SIZE;

EID: 84922982401     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.11.045     Document Type: Article

References (79)

1. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462:449-460.
2. Kim J., Mooney D.J. Invivo modulation of dendritic cells by engineered materials: towards new cancer vaccines. Nano Today 2011, 6:466-477.
3. Lin A.Y., Mattos Almeida J.P., Bear A., Liu N., Luo L., Foster A.E., et al. Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy. PLoS One 2013, 8. e63500.
4. Lee I.H., Kwon H.K., An S., Kim D., Kim S., Yu M.K., et al. Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy invivo. Angew Chem Int Ed 2012, 51:8800-8805.
5. Cruz L.J., Rueda F., Cordobilla B., Simón L., Hosta L., Albericio F., et al. Targeting nanosystems to human DCs via Fc receptor as an effective strategy to deliver antigen for immunotherapy. Mol Pharm 2011, 8:104-116.
6. De Souza Rebouças J., Esparza I., Ferrer M., Sanz M.L., Irache J.M., Gamazo C. Nanoparticulate adjuvants and delivery systems for allergen immunotherapy. JBiomed Biotechnol 2012, 2012.
7. Broos S., Lundberg K., Akagi T., Kadowaki K., Akashi M., Greiff L., et al. Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy. Vaccine 2010, 28:5075-5085.
8. Zolnik B.S., González-Fernández Á., Sadrieh N., Dobrovolskaia M.A. Minireview: nanoparticles and the immune system. Endocrinology 2010, 151:458-465.
9. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007, 2:469-478.
10. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
11. Kreutz M., Tacken P.J., Figdor C.G. Targeting dendritic cells-why bother?. Blood 2013, 121:2836-2844.
12. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
13. Abbas A.K., Sharpe A.H. Dendritic cells giveth and taketh away. Nat Immunol 2005, 6:227-228.
14. Sharp F.A., Ruane D., Claass B., Creagh E., Harris J., Malyala P., et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 2009, 106:870-875.
15. Reddy S.T., Swartz M.A., Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 2006, 27:573-579.
16. Novak N. Targeting dendritic cells in allergen immunotherapy. Immunol Allergy Clin N Am 2006, 26:307-319.
17. Frick S.U., Bacher N., Baier G., Mailänder V., Landfester K., Steinbrink K. Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4+ T cell activation. Macromol Biosci 2012, 12:1637-1647.
18. Aguilar J.C., Rodríguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25:3752-3762.
19. Zaman M., Good M.F., Toth I. Nanovaccines and their mode of action. Methods 2013, 60:226-231.
20. Klimek L., Willers J., Hammann-Haenni A., Pfaar O., Stocker H., Mueller P., et al. Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy 2011, 41:1305-1312.
21. Pali-Schöll I., Szöllösi H., Starkl P., Scheicher B., Stremnitzer C., Hofmeister A., et al. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. Eur J Pharm Biopharm 2013, 85:656-664.
22. Moros M., Hernáez B., Garet E., Dias J.T., Sáez B., Grazú V., et al. Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake. ACS Nano 2012, 6:1565-1577.
23. Lunov O., Syrovets T., Loos C., Beil J., Delacher M., Tron K., et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 2011, 5:1657-1669.
24. Liu Y., Shipton M.K., Ryan J., Kaufman E.D., Franzen S., Feldheim D.L. Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal Chem 2007, 79:2221-2229.
25. Lin A.Y., Lunsford J., Bear A.S., Young J.K., Eckels P., Luo L., et al. High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells invitro. Nanoscale Res Lett 2013, 8:1-11.
26. Kim S., Choi I.H. Phagocytosis and endocytosis of silver nanoparticles induce interleukin-8 production in human macrophages. Yonsei Med J 2012, 53:654-657.
27. Dobrovolskaia M.A., Aggarwal P., Hall J.B., McNeil S.E. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495.
28. Chiodo F., Marradi M., Park J., Ram A.F.J., Penadés S., Van Die I., et al. Galactofuranose-coated gold nanoparticles elicit a pro-inflammatory response in human monocyte-derived dendritic cells and are recognized by DC-SIGN. ACS Chem Biol 2014, 9:383-389.
29. Yen H.J., Hsu S.H., Tsai C.L. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009, 5:1553-1561.
30. Tsai C.Y., Lu S.L., Hu C.W., Yeh C.S., Lee G.B., Lei H.Y. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. JImmunol 2012, 188:68-76.
31. Mottram P.L., Leong D., Crimeen-Irwin B., Gloster S., Xiang S.D., Meanger J., et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol Pharm 2007, 4:73-84.
32. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38:1404-1413.
33. Niikura K., Matsunaga T., Suzuki T., Kobayashi S., Yamaguchi H., Orba Y., et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses invitro and invivo. ACS Nano 2013, 7:3926-3938.
34. Chua B.Y., Al Kobaisi M., Zeng W., Mainwaring D., Jackson D.C. Chitosan microparticles and nanoparticles as biocompatible delivery vehicles for peptide and protein-based immunocontraceptive vaccines. Mol Pharm 2012, 9:81-90.
35. Moyano D.F., Goldsmith M., Solfiell D.J., Landesman-Milo D., Miranda O.R., Peer D., et al. Nanoparticle hydrophobicity dictates immune response. JAm Chem Soc 2012, 134:3965-3967.
36. Blank F., Gerber P., Rothen-Rutishauser B., Sakulkhu U., Salaklang J., De Peyer K., et al. Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011, 5:606-621.
37. Cathcart N., Kitaev V. Silver nanoclusters: single-stage scaleable synthesis of monodisperse species and their chirooptical properties. JPhys Chem C 2010, 114:16010-16017.
38. Jin R. Quantum sized, thiolate-protected gold nanoclusters. Nanoscale 2010, 2:343-362.
39. Hötzer B., Medintz I.L., Hildebrandt N. Fluorescence in nanobiotechnology: sophisticated fluorophores for novel applications. Small 2012, 8:2297-2326.
40. Wu Z., Jin R. On the ligand's role in the fluorescence of gold nanoclusters. Nano Lett 2010, 10:2568-2573.
41. Aldeek F., Muhammed M.A.H., Palui G., Zhan N., Mattoussi H. Growth of highly fluorescent polyethylene glycol- and zwitterion- functionalized gold nanoclusters. ACS Nano 2013, 7:2509-2521.
42. Jin R., Qian H., Wu Z., Zhu Y., Zhu M., Mohanty A., et al. Size focusing: a methodology for synthesizing atomically precise gold nanoclusters. JPhys Chem Lett 2010, 1:2903-2910.
43. Díez I., Pusa M., Kulmala S., Jiang H., Walther A., Goldmann A.S., et al. Color tunability and electrochemiluminescence of silver nanoclusters. Angew Chem Int Ed 2009, 48:2122-2125.
44. Zheng J., Nicovich P.R., Dickson R.M. Highly fluorescent noble-metal quantum dots. Annu Rev Phys Chem 2007, 58:409-431.
45. Le Guevel X., Daum N., Schneider M. Synthesis and characterization of human transferrin-stabilized gold nanoclusters. Nanotechnology 2011, 22:275103-275107.
46. Xie J., Zheng Y., Ying J.Y. Protein-directed synthesis of highly fluorescent gold nanoclusters. JAm Chem Soc 2009, 131:888-889.
47. Kumar S., Bolan M.D., Bigioni T.P. Glutathione-stabilized magic-number silver cluster compounds. JAm Chem Soc 2010, 132:13141-13143.
48. Le Guevel X., Trouillet V., Spies C., Li K., Laaksonen T., Auerbach D., et al. High photostability and enhanced fluorescence of gold nanoclusters by silver doping. Nanoscale 2012, 4:7624-7631.
49. Negishi Y., Nobusada K., Tsukuda T. Glutathione-protected gold clusters revisited: bridging the gap between gold(I)-thiolate complexes and thiolate-protected gold nanocrystals. JAm Chem Soc 2005, 127:5261-5270.
50. Petty J.T., Story S.P., Hsiang J.C., Dickson R.M. DNA-templated molecular silver fluorophores. JPhys Chem Lett 2013, 4:1148-1155.
51. Han B., Wang E. Oligonucleotide-stabilized fluorescent silver nanoclusters for sensitive detection of biothiols in biological fluids. Biosens Bioelectron 2011, 26:2585-2589.
52. Shang L., Dong S. Sensitive detection of cysteine based on fluorescent silver clusters. Biosens Bioelectron 2009, 24:1569-1573.
53. Le Guevel X. Recent advances on the synthesis of metal quantum nanoclusters and their application for bioimaging. IEEE J Sel Top Quantum Electron 2014, 20.
54. Retnakumari A., Setua S., Menon D., Ravindran P., Muhammed H., Pradeep T., et al. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology 2010, 21.
55. Shang L., Dörlich R.M., Brandholt S., Schneider R., Trouillet V., Bruns M., et al. Facile preparation of water-soluble fluorescent gold nanoclusters for cellular imaging applications. Nanoscale 2011, 3:2009-2014.
56. Liu J., Yu M., Zhou C., Yang S., Ning X., Zheng J. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. JAm Chem Soc 2013, 135:4978-4981.
57. Zhou C., Long M., Qin Y., Sun X., Zheng J. Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed 2011, 50:3168-3172.
58. Zhang X.D., Wu D., Shen X., Liu P.X., Fan F.Y., Fan S.J. Invivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 2012, 33:4628-4638.
59. Wang J., Zhang G., Li Q., Jiang H., Liu C., Amatore C., et al. Invivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters. Sci Rep 2013, 3:1157.
60. Manson J., Kumar D., Meenan B.J., Dixon D. Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media. Gold Bull 2011, 44:99-105.
61. Susumu K., Uyeda H.T., Medintz I.L., Pons T., Delehanty J.B., Mattoussi H. Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands. JAm Chem Soc 2007, 129:13987-13996.
62. Park J., Nam J., Won N., Jin H., Jung S., Jung S., et al. Compact and stable quantum dots with positive, negative, or zwitterionic surface: specific cell interactions and non-specific adsorptions by the surface charges. Adv Funct Mater 2011, 21:1558-1566.
63. Mei B.C., Susumu K., Medintz I.L., Mattoussi H. Polyethylene glycol-based bidentate ligands to enhance quantum dot and gold nanoparticle stability in biological media. Nat Protoc 2009, 4:412-423.
64. Lewis D.J., Day T.M., MacPherson J.V., Pikramenou Z. Luminescent nanobeads: attachment of surface reactive Eu(III) complexes to gold nanoparticles. Chem Commun 2006, 1433-1435.
65. Zhu M., Aikens C.M., Hollander F.J., Schatz G.C., Jin R. Correlating the crystal structure of A thiol-protected Au25 cluster and optical properties. JAm Chem Soc 2008, 130:5883-5885.
66. Oh E., Fatemi F.K., Currie M., Delehanty J.B., Pons T., Fragola A., et al. PEGylated luminescent gold nanoclusters: synthesis, characterization, bioconjugation, and application to one- and two-photon cellular imaging. Part Part Syst Charact 2013, 30:453-466.
67. Qian H., Zhu M., Wu Z., Jin R. Quantum sized gold nanoclusters with atomic precision. Acc Chem Res 2012, 45:1470-1479.
68. Tomić S., Dokić J., Vasilijić S., Ogrinc N., Rudolf R., Pelicon P., et al. Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells invitro. PLoS One 2014, 9.
69. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
70. Li K., Schneider M. Quantitative evaluation and visualization of size effect on cellular uptake of gold nanoparticles by multiphoton imaging-UV/Vis spectroscopic analysis. JBiomed Opt 2014, 19:101505. 1-11.
71. Ilinskaya A.N., Dobrovolskaia M.A. Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol 2014, 171:3988-4000.
72. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982, 42:1530-1536.
73. Kleijmeer M.J., Morkowski S., Griffith J.M., Rudensky A.Y., Geuze H.J. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. JCell Biol 1997, 139:639-649.
74. Zhang L.W., Bäumer W., Monteiro-Riviere N.A. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine 2011, 6:777-791.
75. Yan M., Peng J., Jabbar I.A., Liu X., Filgueira L., Frazer I.H., et al. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology 2004, 324:297-310.
76. Dunn K.W., Kamocka M.M., McDonald J.H. Apractical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol 2011, 300:C723-C742.
77. Yang L., Shang L., Nienhaus G.U. Mechanistic aspects of fluorescent gold nanocluster internalization by live HeLa cells. Nanoscale 2013, 5:1537-1543.
78. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
79. Chaves P., Torres M.J., Aranda A., Lopez S., Canto G., Blanca M., et al. Natural killer-dendritic cell interaction in lymphocyte responses in hypersensitivity reactions to betalactams. Allergy: Eur J Allergy Clin Immunol 2010, 65:1600-1608.